glp receptor 1 agonists GLP1 Agonists—Effects beyond Obesity and Diabetes GLP-1 Agonists - What is
Description
Understanding peptides for gut health becomes especially relevant for researchers experiencing persistent GI symptoms who want to support gastrointestinal function during their metabolic protocol
Head-to-head trials against semaglutide are recruiting and have not been reported
Theres also Zepbound, Mounjaro, Trulicity and Victoza and many more on the horizon for people with obesity or Type 2 diabetes
One more thing
Wilding, JPH, Batterham, RL, Calanna, S, et al
doi: 10.2337/diabetes.52.7.1786 [DOI] [PubMed] [Google Scholar] 121
